Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Manish Patel, MD
Florida Cancer Specialist
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Davis Comprehensive Cancer Center
Sacramento, California, United States
- James R. Berenson, Md., Inc.
West Hollywood, California, United States
- Florida Cancer Specialists
Lake Mary, Florida, United States
- Florida Cancer Specialists
Sarasota, Florida, United States
- American Oncology Partners of Maryland, Pa
Bethesda, Maryland, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2020
- Primary completion
- 30 Mar 2022
- Completion
- 30 Mar 2022
- Last update posted
- 29 Feb 2024
- Registered enrollment
- 13
- Registry id
- NCT04671251
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.